SydneyTang Hong Kong, China

Upload Picture

First Name

Sydney

Last Name

Tang

Institution

Country.

Hong Kong, China

Time	Session

2:15 p.m. 3:45 p.m.	Unraveling the Cardiovascular-Kidney-Metabolic Nexus: Making All Work Together for Kidney Care IK02 Parminder KaurJudge Chair United KingdomUniversity of Oxford, UK VineetBehera Chair IndiaConsultant Nephrologist & Professor Medicine, INHS Kalyani, Visakhapatnam Cardiovascular-Kidney-Metabolic Syndrome: What Does it Mean? IK02-01 KatherineTuttle Speaker United StatesUniversity of Washington School of Medicine, Division of Nephrology GLP-1 RA in Kidney Disease: Beyond T2DM Control IK02-02 BeatrizFernandez-Fernandez Speaker SpainHospital Universitario Fundación Jimenez Díaz New Frontiers in CKD Therapy: Endothelin Receptor Antagonists IK02-03 Maria JoseSoler Speaker SpainHospital del Vall d´Hebron Myocardial Infarction in Kidney Disease - What Should a Nephrologist Know? IK02-04 SydneyTang Speaker Hong Kong, China Q&A IK02-05 Amaltas Hall B101-B

Time

Session

2:15 p.m.

3:45 p.m.

Unraveling the Cardiovascular-Kidney-Metabolic Nexus: Making All Work Together for Kidney Care

IK02

Parminder KaurJudge Chair United KingdomUniversity of Oxford, UK

VineetBehera Chair IndiaConsultant Nephrologist & Professor Medicine, INHS Kalyani, Visakhapatnam

Cardiovascular-Kidney-Metabolic Syndrome: What Does it Mean?

IK02-01

KatherineTuttle Speaker United StatesUniversity of Washington School of Medicine, Division of Nephrology
GLP-1 RA in Kidney Disease: Beyond T2DM Control

IK02-02

BeatrizFernandez-Fernandez Speaker SpainHospital Universitario Fundación Jimenez Díaz
New Frontiers in CKD Therapy: Endothelin Receptor Antagonists

IK02-03

Maria JoseSoler Speaker SpainHospital del Vall d´Hebron
Myocardial Infarction in Kidney Disease - What Should a Nephrologist Know?

IK02-04

SydneyTang Speaker Hong Kong, China
Q&A

IK02-05

Amaltas Hall B101-B